Annual Total Long Term Liabilities
$102.94 M
+$6.76 M+7.03%
31 December 2023
Summary:
BioXcel Therapeutics annual total long term liabilities is currently $102.94 million, with the most recent change of +$6.76 million (+7.03%) on 31 December 2023. During the last 3 years, it has risen by +$101.55 million (+7263.59%). BTAI annual total long term liabilities is now at all-time high.BTAI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$108.97 M
-$3.48 M-3.09%
30 September 2024
Summary:
BioXcel Therapeutics quarterly total long term liabilities is currently $108.97 million, with the most recent change of -$3.48 million (-3.09%) on 30 September 2024. Over the past year, it has increased by +$7.32 million (+7.20%). BTAI quarterly long term liabilities is now -11.56% below its all-time high of $123.20 million, reached on 31 March 2024.BTAI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTAI Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.0% | +7.2% |
| 3 y3 years | +7263.6% | +9134.6% |
| 5 y5 years | +100.0% | +10000.0% |
BTAI Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +9216.1% | -11.6% | >+9999.0% |
| 5 y | 5 years | at high | -11.6% | >+9999.0% | |
| alltime | all time | at high | -11.6% |
BioXcel Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $108.97 M(-3.1%) |
| June 2024 | - | $112.45 M(-8.7%) |
| Mar 2024 | - | $123.20 M(+19.7%) |
| Dec 2023 | $102.94 M(+7.0%) | $102.94 M(+1.3%) |
| Sept 2023 | - | $101.65 M(+2.2%) |
| June 2023 | - | $99.49 M(+1.2%) |
| Mar 2023 | - | $98.34 M(+2.2%) |
| Dec 2022 | $96.18 M(+8604.1%) | $96.18 M(+1.8%) |
| Sept 2022 | - | $94.45 M(+47.6%) |
| June 2022 | - | $63.98 M(+6123.5%) |
| Mar 2022 | - | $1.03 M(-7.0%) |
| Dec 2021 | $1.10 M(-21.0%) | $1.10 M(-6.4%) |
| Sept 2021 | - | $1.18 M(-6.0%) |
| June 2021 | - | $1.25 M(-5.5%) |
| Mar 2021 | - | $1.33 M(-5.0%) |
| Dec 2020 | $1.40 M | $1.40 M(-4.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $1.47 M(+61.7%) |
| June 2020 | - | $907.00 K(-5.6%) |
| Mar 2020 | - | $961.00 K(-6.6%) |
| Dec 2019 | $1.03 M(>+9900.0%) | $1.03 M(-3.9%) |
| Sept 2019 | - | $1.07 M(-3.7%) |
| June 2019 | - | $1.11 M(-3.6%) |
| Mar 2019 | - | $1.15 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00 |
| Dec 2016 | $0.00(-100.0%) | - |
| July 2016 | $11.70 K(-99.1%) | - |
| July 2015 | $1.26 M(+553.1%) | - |
| July 2014 | $193.40 K | - |
FAQ
- What is BioXcel Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual total long term liabilities year-on-year change?
- What is BioXcel Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly long term liabilities year-on-year change?
What is BioXcel Therapeutics annual total long term liabilities?
The current annual total long term liabilities of BTAI is $102.94 M
What is the all time high annual total long term liabilities for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual total long term liabilities is $102.94 M
What is BioXcel Therapeutics annual total long term liabilities year-on-year change?
Over the past year, BTAI annual total long term liabilities has changed by +$6.76 M (+7.03%)
What is BioXcel Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of BTAI is $108.97 M
What is the all time high quarterly long term liabilities for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly total long term liabilities is $123.20 M
What is BioXcel Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, BTAI quarterly total long term liabilities has changed by +$7.32 M (+7.20%)